Differential maturation of avidity of IgG antibodies to gp41, p24 and p17 following infection with HIV-1

Clinical and Experimental Immunology

Volumn 103, Issue 2, 1996, Pages 185-191

  Thomas, H I J ^a   Wilson, S ^b   O'Toole, C M ^c   Lister, C M ^d   Saeed, A M ^a   Watkins, R P F ^c   Morgan Capner, P ^a  

^a ROYAL PRESTON HOSPITAL   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c ST MARY S HOSPITAL   (United Kingdom)

^d WITHINGTON HOSPITAL   (United Kingdom)

Author keywords

Anti gp41; Anti p17; Anti p24; Antibody titre; Recent infection; Relative antibody avidity

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; GAG PROTEIN; GLYCOPROTEIN GP 41; HUMAN IMMUNODEFICIENCY VIRUS ANTIGEN; IMMUNOGLOBULIN G; PROTEIN P17; UNCLASSIFIED DRUG;

ADULT; ANTIBODY AFFINITY; ARTICLE; CLINICAL ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PRIORITY JOURNAL; SEROCONVERSION;

EID: 0030067244     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1996.951642.x     Document Type: Article

References (33)

1. Dax EM. HIV testing and staging, disease progression and markers. Curr Opin Infect Dis 1993; 6:191-9.
2. Hammer S, Crupacker C, D'Aquila R et al. Use of serological assays for detection of human immunodeficiency virus in clinical trials: recommendations of the AIDS Clinical Trials Group Virology Committee. J Clin Microbiol 1993; 31:2557-64.
3. Joller-Jemelka HI, Joller PW, Muller F et al. Anti-HIV IgM antibody analysis during early manifestations of HIV infections. AIDS 1987; 1:45-47.
4. Bollinger RC, Kline RL, Francis HL et al. Acid dissociation increases the sensitivity of p24 antigen detection for the evaluation of antiviral therapy and disease progression in asymptomatic human immunodeficiency virus-infected persons. J Infect Dis 1992; 165:913-6.
5. Constantine NT, Callahan JD, Watts DM. The immune system during HIV infection. I. Antibody responses. In: Retroviral testing: essentials for quality control and laboratory diagnosis. Boca Raton: CRC Press Inc. 1992: 15-33.
6. Fauci AS. The human immunodeficiency virus: infectivity and mechanisms of pathogenesis. Science 1988; 239:617-22.
7. Fauci AS, Schnittman SM, Poli G et al. Immunopathogenic mechanisms in human immunodeficiency virus (HIV) infection. Annal Intern Med 1991; 114:678-93.
8. Hughes MD, Stein DS, Gundacker HM et al. Within-subject variation in CD4 lymphocyte count in asymptomatic human immunodeficiency virus infection: implications for patient monitoring. J Infect Dis 1994; 169:28-36.
9. Roitt IM, Brostoff J, Male DK. Immunology, 3rd edn. London: Mosby-Year Book Europe Ltd, 1993: 6-3 6-7.
10. Eisen HN, Siskind GW. Variations in affinities of antibodies during the immune response. Biochemistry 1964; 3:996-1008.
11. Siskind GW, Benecerraf B. Cell selection by antigen in the immune response. Advances Immunol 1969; 10:1-50.
12. Devey ME, Bleasdale K, Lee S et al. Determination of the functional affinity of IgG1 and IgG4 antibodies to tetanus toxoid by isotype-specific solid-phase assays. J Immunol Methods 1988; 106:119-25.
13. Thomas HIJ, Morgan-Capner P. Rubella-specific IgG1 avidity: a comparison of methods. J Virol Methods 1991; 31:219-28.
14. Thomas HIJ, Morgan-Capner P, Enders G et al. Persistence of specific IgM and low avidity specific IgG1 following primary rubella. J Virol Methods 1992; 39:149-55.
15. Steward MW, Stanley CM, Dimarchi R et al. High-affinity antibody induced by immunisation with a synthetic peptide is associated with protection of cattle against foot-and-mouth disease. Immunology 1991; 72:99-103.
16. Thomas HIJ, Morgan-Capner P. Rubella-specific IgG subclass avidity ELISA and its role in the differentiation between primary rubella and rubella reinfection. Epidemiol Infect 1988; 101:591-8.
17. Thomas HIJ, Morgan-Capner P, Meurisse EV. Studies on the avidity of IgG1 subclass antibody specific for varicella-zoster virus. Serodiagn Immunother Infect Dis 1990; 4:371-7.
18. Thomas HIJ, Charlett A, Cubic HA. Specific IgG1 avidity maturation after rubella vaccination; a comparison with avidity maturation after primary infection with wild rubella virus. Serodiagn Immunother Infect Dis 1995; 7:75-80.
19. Thomas HIJ, Morgan-Capner P, Roberts A et al. Persistent rubella-specific IgM reactivity in the absence of recent primary rubella and rubella reinfection. J Med Virol 1992; 36:188-92.
20. + patients with haemophilia: titre and avidity. Clin Exp Immunol 1993; 93:331-6.
21. Chargelegue D, Colvin BT, O'Toole CM. A 7 year analysis of anti-gag (p17 and p24) antibodies in HIV-1 seropositive patients with haemophilia: immunoglobulin titre and avidity are early predictors of clinical course. AIDS 1993; 7:S87-S90.
22. Chargelegue D, Stanley CM, O'Toole CM et al. The affinity of IgG antibodies to gag p24 and p17 in HIV-1 infected patients correlates with disease progression. Clin Exp Immunol 1995; 99:175-81.
23. Radkowski M, Laskus T, Goch A et al. Affinity of anti-gp41 antibody in patients infcted with human immunodeficiency virus type 1. Eur J Clin Invest 1993; 23:455-8.
24. McRae B, Lange JAM, Ascher MS et al. Immune response to HIV p24 core protein during the early phases of human immunodeficiency virus infection. AIDS Res Human Retroviruses 1991; 7: 637-43.
25. O'Farrell N, Tovey SJ, Morgan-Capner P. Transmission of HIV-1 infection after a fight (letter). Lancet 1992; 339:246.
26. Watkins RPF, Atkins M, Zambon MC, Parry J. A strategy to diagnose recent infection with HIV in a routine virus laboratory. Poster no. POB402440 presented at the IXth AIDS Conference, Abstracts Book Vol. 1, Berlin, 1993.
27. Hedman K, Lappalainen M, Seppälä I et al. Recent primary toxoplasma infection indicated by a low avidity of specific IgG. J Infect Dis 1989; 159:736-40.
28. Bofill M, Janossy G, Lee CA et al. Laboratory control values for CD4 and CD8 T lymphocytes. Implications for HIV-1 diagnosis. Clin Exp Immunol 1992; 88:243-52.
29. Ward KN, Gray JJ, Joslin ME et al. Avidity of IgG antibodies to human herpesvirus-6 distinguishes primary from recurrent infection in organ transplant recipients and excludes cross-reactivity with other herpes viruses. J Med Virol 1993; 39:44-49.
30. Helmann R, Fischer A, Matuschke A et al. HIV-Antigen und Antikörper wärhrend des Verlaufs der HIV-infektion. AIDS-Forschung (AIFO) 1987; 8:29-35.
31. Weber JN, Weiss RA, Roberts C et al. Human immunodeficiency virus infection in two cohorts of homosexual men: neutralising sera and association of anti-gag antibody with prognosis. Lancet 1987; i: 119-22.
32. Lange JMA, Paul DA, Huisman HG et al. Persistent HIV anti-genaemia and decline of HIV core antibodies associated with transmission to AIDS. Brit Med J 1986; 295:1459-62.
33. Steward MW, Steengard J, Antibody affinity; thermodynamic aspects and biological significance. Boca Raton: F.L.C.R.C. Press, 1983.